Transforming growth factorβ1 transactivates EGFR via an H2O2-dependent mechanism in squamous carcinoma cell line

Cancer Letters

Volumn 290, Issue 1, 2010, Pages 43-48

  Lee, EunAh ^a   Yi, Jae Youn ^b   Chung, Eunkyung ^c   Son, Youngsook ^a  

^a Musculoskeletal Bioorgan Center   (South Korea)

^b Korea Institute of Radiation and Medical Science   (South Korea)

^c Hallym University   (South Korea)

Author keywords

Crosstalk; EGFR; H2O2; TGF ; Transactivation

Indexed keywords

CATALASE; ENZYME INHIBITOR; EPIDERMAL GROWTH FACTOR RECEPTOR; HYDROGEN PEROXIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NEUTRALIZING ANTIBODY; TRANSFORMING GROWTH FACTOR BETA1; MITOGEN ACTIVATED PROTEIN KINASE; REACTIVE OXYGEN METABOLITE;

ARTICLE; CARCINOMA CELL; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SQUAMOUS CELL CARCINOMA; GENE EXPRESSION REGULATION; GENETICS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TUMOR CELL LINE;

CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYDROGEN PEROXIDE; IMMUNOBLOTTING; IMMUNOPRECIPITATION; PHOSPHORYLATION; REACTIVE OXYGEN SPECIES; RECEPTOR CROSS-TALK; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 77249151403     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2009.08.022     Document Type: Article

References (39)

1. 1 in the epidermis. Am. J. Pathol. 159 (2001) 2147-2157
2. 1 involves multiple signaling pathways. J. Invest. Dermatol. 116 (2001) 266-274
3. Takehara K. Growth regulation of skin fibroblasts. J. Dermatol. Sci. 24 (2000) S70-S77
4. Yue J., and Mulder K.M. TGF-β signal transduction in epithelial cells. Pharmacol. Ther. 91 (2001) 1-34
5. Choi Y., and Fuchs E. TGF-β and retinoic acid: regulators of growth and modifiers of differentiation in human epidermal cells. Cell Regul. 1 (1990) 791-809
6. Min B.M., Woo K.M., Lee G., and Park N.H. Terminal differentiation of normal human oral keratinocytes is associated with enhanced cellular TGF-β and phospholipase C-gamma 1 levels and apoptotic cell death. Exp. Cell Res. 249 (1999) 377-385
7. 1-mediated epithelial to mesenchymal transition is accompanied by invasion in the SiHa cell line. Eur. J. Cell. Biol. 81 (2002) 457-468
8. 1-induced EMT can occur independently of its proapoptotic effects and is aided by EGFR activation. Am. J. Physiol. Renal. Physiol. 290 (2006) F1202-F1212
9. Stover D.G., Bierie B., and Moses H.L.A. A delicate balance: TGF-β and the tumor microenvironment. J. Cell. Biochem. 101 (2007) 851-861
10. Uchiyama-Tanaka Y., Matsubara H., Nozawa Y., Murasawa S., Mori Y., Kosaki A., Maruyama K., Masaki H., Shibasaki Y., Fujiyama S., Nose A., Iba O., Hasagawa T., Tateishi E., Higashiyama S., and Iwasaka T. Angiotensin II signaling and HB-EGF shedding via metalloproteinase in glomerular mesangial cells. Kidney Int. 60 (2001) 2153-2163
11. Eguchi S., Numaguchi K., Iwasaki H., Matsumoto T., Yamakawa T., Utsunomiya H., Motley E.D., Kawakatsu H., Owada K.M., Hirata Y., Marumo F., and Inagami T. Calcium-dependent EGFR transactivation mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells. J. Biol. Chem. 273 (1998) 8890-8896
12. Chen J., Chen J.K., Neilson E.G., and Harris R.C. Role of EGFR activation in angiotensin II-induced renal epithelial cell hypertrophy. J. Am. Soc. Nephrol. 17 (2006) 1615-1623
13. Moriguchi Y., Matsubara H., Mori Y., Murasawa S., Masaki H., Maruyama K., Tsutsumi Y., Shibasaki Y., Tanaka Y., Nakajima T., Oda K., and Iwasaka T. Angiotensin II-induced transactivation of EGFR regulates fibronectin and TGF-β synthesis via transcriptional and posttranscriptional mechanisms. Circ. Res. 84 (1999) 1073-1084
14. Perlman A., Lawsin L.M., Kolachana P., Saji Jr. M., Moore J., and Ringel M.D. Angiotensin II regulation of TGF-β in murine mesangial cells involves both PI3 kinase and MAP kinase. Ann. Clin. Lab. Sci. 34 (2004) 277-286
15. El-Shewy H.M., Kelly F.L., Barki-Harrington L., and Luttrell L.M. Ectodomain shedding-dependent transactivation of EGFR in response to IGF-1. Mol. Endocrinol. 18 (2004) 2727-2739
16. Zhou Q., Meng D., Yan B., Jiang B.H., and Fang J. Transactivation of EGFR by IGF-1 requires basal hydrogen peroxide. FEBS Lett. 580 (2006) 5161-5166
17. 1/2 activation in COS-7 cells. J. Biol. Chem. 275 (2000) 22583-22589
18. Ahmad T., Farnie G., Budred N.J., and Anderson N.G. The mitogenic action of IGF-1 in normal human mammary epithelial cells requires the EGFR tyrosine kinase. J. Biol. Chem. 279 (2004) 1713-1719
19. Uchiyama-Tanaka Y., Matsubara H., Mori Y., Kosaki A., Kishimoto N., Amano K., Higashiyama S., and Iwasaka T. Involvement of HB-EGF and EGFR transactivation in TGF-β-mediated fibronectin expression in mesangial cells. Kidney Int. 62 (2002) 799-808
20. 1 in hepatocytes. Oncogene 24 (2005) 4580-4587
21. Murillo M.M., Carmona-Cuenca I., del Castillo G., Ortiz C., Roncero C., Sanchez A., Fernandez M., and Fabregat I. Activation of NADPH oxidase by TGF-β in hepatocytes mediates up-regulation of EGFR ligands through a nuclear factor-kappaB-dependent mechanism. Biochem. J. 405 (2007) 251-259
22. 2 by TGF-β in Swiss 3T3 fibroblasts. Cell. Signal. 11 (1999) 677-683
23. 1-induced IL-6 expression. J. Immunol. 165 (2000) 2190-2197
24. 1. J. Biol. Chem. 270 (1995) 30334-30338
25. Rhee S.G. Redox signaling: hydrogen peroxide as intracellular messenger. Exp. Mol. Med. 31 (1999) 53-59
26. Joo C.-K., Kim H.-S., Park J.-Y., Seomun Y., Son M.-Y., and Kim J.-T. Ligand release-independent transactivation of epidermal growth factor receptor by transforming growth factor-β involves multiple signaling pathways. Oncogene 27 (2008) 614-628
27. mapk in proliferating cultures of epithelial cells. J. Biol. Chem. 270 (1995) 7117-7124
28. Hartsough M.T., Frey R.S., Zipfel P.A., Buard A., Cook S.J., McCormick F., and Mulder K.M. Altered transforming growth factorβ signaling in epithelial cells when Ras activation is blocked. J. Biol. Chem. 271 (1996) 22368-22375
29. Frey R.S., and Mulder K.M. Involvement of extracellular signal-related kinase 2 and stress-activated protein kinase/Jun N-terminal kinase activation by transforming growth factor β in the negative growth control of breast cancer cells. Cancer Res. 57 (1997) 628-633
30. Wetker R., and Bohmer F.D. Transactivation joins multiple tracks to the ERK/MAPK cascade. Nat. Rev. Mol. Cell. Biol. 4 (2003) 651-657
31. Rosen L.B., and Greenberg M.E. Stimulation of growth factor receptor signal transduction by activation of voltage-sensitive calcium channels. Proc. Natl. Acad. Sci. USA 93 (1996) 1113-1118
32. Zwick E., Hackel P.O., Prenzel N., and Ullrich A. The EGF receptor as central transducer of heterologous signaling systems. Trends Pharmacol. Sci. 20 (1999) 408-412
33. Levkowitz G., Waterman H., Ettenberg S.A., Katz M., Tsygankove A.Y., Alroy I., Lavi S., Iwai K., Reiss Y., Ciechanover A., Lipkowitz S., and Yarden Y. Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1. Mol. Cell. 4 (1999) 1029-1040
34. 1101 is associated with modulation of receptor function. J. Biol. Chem. 274 (1999) 8335-8345
35. 1 inhibits human keratinocyte proliferation by upregulation of receptor-type tyrosine phosphatase R-PTP-κ gene expression. Biochem. Biophys. Res. Commun. 228 (1996) 807-812
36. Gloor S.M., Weber A., Adach N., and Frei K. Interleukin-1 modulates protein tyrosine phosphatase activity and permeability of brain endothelial cells. Biochem. Biophys. Res. Commun. 239 (1997) 804-809
37. 1 inhibits T-bet induction by IFN-γ in murine CD4+ T cells through the protein tyrosine phosphatase Src homology region 2 domain-containing phosphatase-1. J. Immunol. 175 (2005) 5666-5674
38. DeYulia Jr. G.J., and Carcamo J.M. EGF receptor-ligand interaction generates extracellular hydrogen peroxide that inhibits EGFR-associated protein tyrosine phosphatases. Biochem. Biophys. Res. Commun. 334 (2005) 38-42
39. Keilhack H., Tenev T., Nyakatura E., Godovac-Zimmermann J., Nielsen L., Seedorf K., and Böhmer F.-D. Phosphotyrosine 1173 mediates binding of the protein-tyrosine phosphatase SHP-1 to the epidermal growth factor receptor and attenuation of receptor signaling. J. Biol. Chem. 273 (1998) 24839-24846